Back to Search
JONATHAN GARST, MD
MD
Neurological Surgery Physician
NPI: 1811423940IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
2024-03186(NC)2024017003(MO)
CMS Specialties
PrimaryNEUROSURGERY
Education
LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Class of 2017
Research & Publications (20)
Safety of topotecan in the treatment of recurrent small-cell lung cancer and ovarian cancer.
PMID 17181452·Expert Opin Drug Saf·2007
6-review
Topotecan in the treatment of elderly patients with relapsed small-cell lung cancer.
PMID 16354314·Clin Lung Cancer·2005
4-observational
Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels.
PMID 19254679·J Pain·2009
8-other
Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distress.
PMID 17942229·Pain·2008
8-other
Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study.
PMID 18988290·Cancer·2008
8-other
The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response.
PMID 17276621·Int J Radiat Oncol Biol Phys·2007
8-other
Topotecan: An evolving option in the treatment of relapsed small cell lung cancer.
PMID 18516270·Ther Clin Risk Manag·2007
8-other
A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer.
PMID 17545847·J Thorac Oncol·2007
3-trial
Long term metabolic arrest and recovery of HEK293 spheroids involves NF-kappaB signaling and sustained JNK activation.
PMID 16155929·J Cell Physiol·2006
8-other
Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.
PMID 17254524·Curr Oncol Rep·2006
6-review
A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.
PMID 17163259·Clin Drug Investig·2006
3-trial
Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer.
PMID 17005294·Lung Cancer·2006
3-trial
Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury.
PMID 16904841·Int J Radiat Oncol Biol Phys·2006
8-other
Transcriptional response of Saccharomyces cerevisiae to desiccation and rehydration.
PMID 16332871·Appl Environ Microbiol·2005
8-other
Application of molecular modeling to analysis of inhibition of kinesin motor proteins of the BimC subfamily by monastrol and related compounds.
PMID 17191952·Chem Biodivers·2005
4-observational
A pilot study investigating the utility of the cognitive-behavioral model of insomnia in early-stage lung cancer patients.
PMID 16125031·J Pain Symptom Manage·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1130 N CHURCH ST STE 200
GREENSBORO, NC 27401 - Phone
- (336) 272-4578
Quick Facts
- NPI
- 1811423940
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile